EEG -guided Characterization, Monitoring, and Therapy for Neurological and Neurocognitive Sequelae of COVID‐19 and Long COVID

Authors

  • Slav Danev Medeia Inc, Santa Barbara, CA, USA Author
  • Tori R Tucker Department of Developmental and Cell Biology, University of California Irvine, California, USA Author
  • Jonathan RT Lakey Department of Surgery, University of California Irvine, California, USA Author

DOI:

https://doi.org/10.33425/2692-7918.1034

Keywords:

COVID-19, brain electromagnetic tomography, quantitative EEG

Abstract

The long-term effect of the newly emerged COVID-19 (SARS-CoV-2) virus has not been fully understood. It has been reported that several patients experienced neurological and neurocognitive problems after getting infected by the COVID-19 virus. This paper will review how the COVID-19 virus has impacted the brain, will aim to detect the location of COVID-19 in the brain, and will determine if the neurological complications are a result of “direct” or “indirect” effects of the virus on brain cells. Additionally, we will focus on the neurocognitive impact of COVID‐19 and the potential of digital electroencephalography (EEG), quantitative EEG (QEEG) and standardized low resolution brain electromagnetic tomography (sLORETA) to be able to capture, assess, monitor, characterize and facilitate the treatment of both neurological and neurocognitive sequelae seen in COVID‐19 and long COVID.

Downloads

Published

2025-07-25

Issue

Vol. 3 No. 3

Section

Articles